[ad_1]
The fast and aggressive celebration of moving birds. Photo: SVA
The National Veterinary Office (SVA) is involved in a project to develop a vaccine against the deadly Crimean Congo disease. The disease is caused by a virus that is transmitted in particular by the Migratory Birds Migratory Birds Rescue Program.
The virus is currently spreading in Russia, in large parts of Africa, in the Middle East, in East Asia and in south-eastern Europe. It spreads to new areas through ticks on migratory birds or infected animals. They are only carriers of the virus and can not suffer from the disease.
bird migration tick, Hyalomma marginatum, is known to carry the Crimean-Congo hemophilia virus. The fortress did not exist before in Sweden, but during the summer and autumn of 2018, several discoveries have been reported concerning this species in Sweden. However, no report indicates that only these specimens of the tick were infected with the deadly virus.
Lijo John is one of the researchers working on the development of a vaccine against Congo's Crimean Congo bleeding fever. Photo: SVA
There is no vaccine yet to treat the disease. Congolese Crimean Hemorrhagic Fever (CHF). However, a multinational and interdisciplinary research project, the VCHCC vaccine, aims to develop and develop a vaccine. As part of his work, SVA scientist Lijo John has been studying some of the virus's RNA molecules, which could be the key to a future vaccine.
"When we have completed all the initial screening tests, these vaccine candidates will be tested on animals," Lijo John said in an SVA press release.
[ad_2]
Source link
